Coya Therapeutics, Inc. filed 2 current reports with the SEC under Item 5.02, which covers directors and officers leaving or being appointed, the latest on 2026-08-07. Between them they name 2 people, with 2 appointments and 1 departure. Each change below is quoted from the filing and linked to it.
Every change, newest first
Appointed: Mark H. Pavao
This Amendment is being filed solely to report that on August 6, 2026, the Board, upon the recommendation of the Nominating and Corporate Governance Committee, appointed Mr. Pavao to the Audit Committee of the Board, effective immediately.
Departing: Howard Berman, Executive Chairman, effective 2026-04-01
On March 29, 2026, Dr. Howard Berman resigned from the board of directors (the "Board") of Coya Therapeutics, Inc. (the "Company") and from his position as Executive Chairman, each effective as of April 1, 2026.
Appointed: Mark H. Pavao, Director, effective 2026-04-01
On April 1, 2026, upon the recommendation of the Nominating and Corporate Governance Committee, the Board appointed Mark H. Pavao to serve as an independent director, effective April 1, 2026, to fill the vacancy created by Dr. Berman's resignation.
Find people with the same kind of experience as the Executive Chairman at Coya Therapeutics, Inc., with the record behind each one.
Find candidates like Executive Chairman at Coya Therapeutics, Inc.New leaders review vendors and budgets in their first months. Get an alert the next time Coya Therapeutics, Inc. is in the news or changes leadership.
Get an alert when Coya Therapeutics, Inc. changes leadershipTools for this story
Each opens in a new tab, filled in for Coya Therapeutics, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.